Alzheimer’s disease doesn’t have a single cause. It results from a cascade of biological processes, including the buildup of toxic proteins in the brain, chronic inflammation, genetic vulnerability, and metabolic dysfunction, all interacting over decades before symptoms appear. An estimated 7.1 million Americans currently live with Alzheimer’s, and that number is projected to nearly double by 2060.
Understanding what drives the disease means looking at several overlapping mechanisms. Some you can’t control, like your genes. Others, like sleep quality and metabolic health, offer real points of intervention.
Toxic Protein Buildup: Plaques and Tangles
The two hallmark features of Alzheimer’s are amyloid plaques and tau tangles, both of which physically interfere with how brain cells communicate and survive.
Amyloid plaques form outside brain cells. They start as short strings of amino acids called amyloid-beta peptides. The version with 42 amino acids (known as Aβ42) is the most prone to clumping. These peptides link together into structures called protofilaments, which combine into larger filaments and eventually aggregate into the dense plaques found throughout Alzheimer’s-affected brains. These plaques disrupt the signaling between neurons, essentially creating roadblocks in the brain’s communication network.
Tau tangles form inside brain cells and are arguably more destructive. Tau is a normal protein that stabilizes the internal scaffolding (microtubules) neurons rely on to transport nutrients and signals. In Alzheimer’s, tau becomes overloaded with phosphate groups. Normal tau carries two or three phosphate groups; in Alzheimer’s, that number jumps to five to nine. This chemically altered tau stops doing its stabilizing job and instead pulls normal tau and other stabilizing proteins away from microtubules. The result is that the cell’s internal structure collapses. The damaged tau proteins clump together into twisted filaments, forming the neurofibrillary tangles that are closely correlated with cognitive decline.
The Brain’s Immune System Turns Harmful
The brain has its own immune cells called microglia. In the early stages of Alzheimer’s, microglia try to clean up amyloid plaques and damaged cells. But as the disease progresses, this protective response becomes chronically overactivated and starts causing damage of its own.
In later stages, microglia interact with accumulating tau tangles, and this interaction triggers extensive inflammation and neurodegeneration. Genes involved in the brain’s innate immune defense become highly active, particularly one called complement C3. Microglia expressing C3 release a flood of inflammatory molecules and trigger the proliferation of toxic support cells (called A1 reactive astrocytes) that further harm neurons. What began as a cleanup effort becomes a sustained attack on the brain’s own tissue.
Genetic Risk: The Role of APOE
The strongest known genetic risk factor for the common, late-onset form of Alzheimer’s is a variant of the APOE gene called APOE ε4. Carrying one copy of this variant increases your risk and is associated with developing symptoms at an earlier age. Carrying two copies raises the risk further.
That said, APOE ε4 is not a guarantee. Some people with two copies never develop Alzheimer’s, while many people without the variant do. Rare, early-onset forms of Alzheimer’s (appearing before age 65) are linked to mutations in different genes that directly affect amyloid production, but these account for a small fraction of all cases. For most people, genetics loads the gun, and other factors pull the trigger.
Blood-Brain Barrier Breakdown
The brain is protected by a tightly sealed network of blood vessels called the blood-brain barrier, which controls what enters brain tissue from the bloodstream. Recent imaging and biomarker studies have found that this barrier begins breaking down early in Alzheimer’s, sometimes before any cognitive decline or detectable amyloid buildup. When the barrier leaks, blood-borne proteins and immune cells enter brain tissue where they don’t belong, triggering inflammation and potentially accelerating the accumulation of amyloid and tau.
Insulin Resistance in the Brain
A growing body of evidence connects Alzheimer’s to how the brain uses insulin, a relationship so striking that some researchers have called it “type 3 diabetes.” Insulin in the brain does more than regulate energy. It supports the chemical signaling essential for learning and memory and helps maintain the structure of synaptic connections between neurons.
When brain cells become resistant to insulin, the consequences cascade: neurons die, inflammation increases, oxidative damage accelerates, and the production of a key chemical messenger involved in memory drops. Toxic lipids that build up with metabolic dysfunction worsen this insulin resistance, creating a self-reinforcing cycle. This is one reason why type 2 diabetes and obesity are consistently identified as risk factors for Alzheimer’s.
Sleep and Waste Clearance
The brain has a waste-removal system, sometimes called the glymphatic system, that flushes out metabolic byproducts, including amyloid-beta. This system is built from tunnels formed by a type of brain support cell. Cerebrospinal fluid flows into brain tissue through channels along blood vessels, picks up waste, and carries it out to be processed by the body’s lymphatic system.
This cleaning process largely shuts down while you’re awake. It activates during sleep, particularly during the deep, slow-wave stage. The rhythmic, pulsing brain waves of deep sleep help drive fluid into the spaces between cells, boosting waste removal. In mouse studies, the space between brain cells expanded by 60% during sleep, dramatically increasing the rate at which waste could be flushed out.
Even a single night of sleep deprivation in young, healthy people has been shown to measurably increase amyloid-beta levels in the brain. Over years or decades, chronically poor sleep could meaningfully contribute to the protein buildup that drives Alzheimer’s. This is one of the most actionable risk factors researchers have identified.
Air Pollution and Environmental Exposure
Long-term exposure to fine particulate matter (PM2.5) air pollution is associated with higher rates of new dementia cases. A large study examining nine different emission sources found that pollution from agriculture and open fires had the strongest links to dementia risk. Road traffic, industrial coal combustion, and other energy production sources were also associated with increased risk. These tiny particles can enter the brain through the nasal passages and bloodstream, potentially triggering the chronic inflammation that feeds into Alzheimer’s pathology.
Why It’s Not Just One Thing
The reason Alzheimer’s has been so difficult to treat is that it isn’t driven by a single broken mechanism. Amyloid plaques, tau tangles, neuroinflammation, vascular damage, metabolic dysfunction, and impaired waste clearance all feed into each other. Amyloid buildup activates microglia, which worsen tau pathology, which accelerates neurodegeneration. Poor sleep reduces amyloid clearance, which increases plaque formation. Insulin resistance promotes inflammation, which damages the blood-brain barrier, which allows more harmful substances into brain tissue.
For most people who develop Alzheimer’s, the disease likely begins with some combination of genetic susceptibility, metabolic shifts, vascular changes, and environmental exposures that accumulate over decades. By the time memory problems appear, the underlying processes have typically been active for 15 to 20 years. This long preclinical window is why so much current focus has shifted to identifying and addressing risk factors, like sleep, metabolic health, cardiovascular fitness, and pollution exposure, well before symptoms begin.